Deciphering the role of dietary modifications and gut dysbiosis in Non-Alcoholic Fatty Liver Disease
Non-alcoholic fatty liver disease (NAFLD) is emerging as a major health concern and economic burden worldwide. Approximately one-third of the total population is affected by NAFLD. The more aggressive form of NAFLD, non-alcoholic steatohepatitis (NASH) could progress to liver failure, fibrosis, cirr...
Saved in:
| Main Authors: | Meenakshi Vachher, Kohinoor Kaur, Manisha Marothia, Archana Burman, Deepanjana, Savita Bansal |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-06-01
|
| Series: | Human Nutrition & Metabolism |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666149725000088 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current insights into the interplay between gut microbiota-derived metabolites and metabolic-associated fatty liver disease
by: Rachmad Anres Dongoran, et al.
Published: (2023-01-01) -
The role of microbiota dysbiosis in Parkinson’s disease: Pathophysiology and therapeutic opportunities
by: Shabnam Santos, et al.
Published: (2025-09-01) -
Gut microbiota and metabolomics in metabolic dysfunction-associated fatty liver disease: interaction, mechanism, and therapeutic value
by: Luyu Wang, et al.
Published: (2025-07-01) -
Impact of Gut Microbiota on the Development of Diseases
by: Karolina Winiarek, et al.
Published: (2024-11-01) -
Gut-eye axis
by: Weixin Zheng, et al.
Published: (2025-08-01)